Patient-Centered Field Research in Medtech
In this Before the Build episode, Eric Olson and Paul Charlebois reflect on the value of patient-centered field research—and how firsthand observation can reframe design priorities and impact outcomes in profound ways.
Paul shares an eye-opening story from a research session observing Mohs surgery, a specialized outpatient procedure for removing skin cancer. At first glance, the experience seemed overwhelming: patients were marked with dotted lines, then underwent facial excisions that appeared disfiguring. But over the course of the day, something deeper unfolded. The real story wasn’t just the clinical effectiveness of the surgery, but how patients experienced care, recovery, and dignity throughout the process.
The team observed how the clinic balanced harsh realities—patients with visible, temporary facial trauma waiting together in a shared space—with quiet, thoughtful design choices: no mirrors, careful pacing, and empathetic reconstruction work. These details emphasized the importance of viewing each case as more than a procedure.
Why Patient-Centered Field Research Matters
As Eric and Paul discuss, patient-centered field research often reveals more than what a design spec or user survey ever could. When engineers and developers step into real clinical environments, they can witness the emotional and procedural nuances that define patient experience. This approach can ultimately lead to better market adoption, stronger user satisfaction, and more impactful innovation.
Even when your device isn’t central to the treatment itself, being present in the broader clinical journey gives design teams critical insight into where they can reduce friction and add value.
Enjoying Before the Build? Sign up to get new episodes sent to your inbox.
Related Resources
Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.
Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.
Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.
In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.